Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Medical Oncology (Northwood, London, England)|March 30, 2017
PD-L2: A prognostic marker in chromophobe renal cell carcinoma?Franziska Erlmeier, Wilko Weichert, Michael Autenrieth, et al.
Clinical Genitourinary Cancer|November 20, 2016
Therapy of Treatment-Related Hypertension in Metastatic Renal-Cell Cancer Patients Receiving SunitinibPhilipp Ivanyi, Gernot Beutel, Nicole Drewes, et al.
European Journal of Haematology|June 11, 2005
Inflammatory pseudotumor of the lung following invasive aspergillosis in a patient with chronic graft-vs.-host diseaseConstanze Priebe-Richter, Philipp Ivanyi, Jan Buer, et al.
Medical Oncology (Northwood, London, England)|August 20, 2014
Interstitial lung disease during targeted therapy in metastatic renal cell carcinoma: a case series from three centresPhilipp Ivanyi, Thomas Fuehner, Meike Adam, et al.
Aktuelle Urologie|October 7, 2020
[Interdisciplinary recommendations for the treatment of advanced metastatic renal cell carcinoma]Kurt Miller, Lothar Bergmann, Christian Doehn, et al.
Plos One|December 20, 2012
Human regulatory T cells of G-CSF mobilized allogeneic stem cell donors qualify for clinical applicationSya N Ukena, Sarvari Velaga, Lilia Goudeva, et al.
Molecular and Clinical Oncology|October 2, 2020
Hepatic toxicity during regorafenib treatment in patients with metastatic gastrointestinal stromal tumorsPhilipp Ivanyi, Hendrik Eggers, Mareike Hornig, et al.
Oncology Research and Treatment|January 19, 2022
A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study)Viktor Grünwald, Thomas Hilser, Johannes Meiler, et al.
Oncology Research and Treatment|May 29, 2019
Sarcoid-Like Lesions Mimicking Pulmonary Metastasis: A Case Series and Review of the LiteratureHendrik Eggers, Marcus Krüger, Katharina Stange, et al.
World Journal of Urology|August 2, 2022
Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?Hendrik Eggers, Christoph Schünemann, Viktor Grünwald, et al.
Pageof 10